BackRemeGen , Ltd. Overview

RemeGen , Ltd. Current Assets

Track RemeGen , Ltd.'s current assets ($6.6B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$6.62B
↑ 145.45% YoYΔ $3.92B vs prior year quarter

Peer trimmed avg / median

Loading

RemeGen , Ltd. Current Assets History

Loading

RemeGen , Ltd. vs. peers: Current Assets Comparison

Loading

RemeGen , Ltd. Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

RemeGen , Ltd. (REGMF) FAQ

As of the most recent data (June 2026), REGMF shows a current assets of $6.6B. That compares with $2.7B in the prior-year period — up 145.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, REGMF's current assets is now $6.6B (was $2.7B) — a 145.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether RemeGen , Ltd. is outperforming or lagging.

Tracking REGMF's current assets over time shows whether RemeGen , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $6.6B That compares with $2.7B in the prior-year period — up 145.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has RemeGen , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $6.6B) with ownership activity and broader fundamentals.

RemeGen , Ltd.'s current assets is $6.6B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.